Related Experiment Videos
Warfarin-induced haemorrhagic infarction of the small bowel
V P Muralikrishnan1, D H Thomas, P N Haray
1Department of Surgery, Prince Charles Hospital, Merthyr Tydfil, UK.
Clinical and Laboratory Haematology
|November 10, 1998
Abstract:
Haemorrhagic infarction of the small bowel is a rare complication of warfarin therapy. We take this opportunity to report a case that needed a resection of the small bowel.
Insights
Haemorrhagic infarction of the small bowel is a rare complication of warfarin therapy. This case report highlights the need for small bowel resection due to this serious adverse event.
Area of Science:
- Gastroenterology
- Vascular Surgery
- Pharmacology
Background:
- Warfarin is an anticoagulant medication used to prevent blood clots.
- Haemorrhagic infarction of the small bowel is a rare but serious complication associated with anticoagulant therapy.
- Early recognition and intervention are crucial for managing this condition.
Observation:
- A case of small bowel haemorrhagic infarction occurred during warfarin therapy.
- The patient required surgical intervention.
- Small bowel resection was necessary to manage the complication.
Findings:
- This case illustrates a rare gastrointestinal complication of warfarin.
- Surgical resection of the affected small bowel segment was the required treatment.
- Warfarin-induced mesenteric ischaemia can lead to significant morbidity.
Implications:
- Clinicians should consider warfarin-induced mesenteric ischaemia in patients presenting with acute abdominal symptoms.
- Prompt diagnosis and surgical management are essential for favourable outcomes.
- Further research into the mechanisms and prevention of this complication is warranted.